Nanosensors to Detect Protease Activity <em>In Vivo</em> for Noninvasive Diagnostics

• DOI: 10.3791/57937-v
• Publication Date: 2021-11-19T13:17:49Z
• Authors: Brandon Alexander...; Quoc D. Mac; Gabriel A. Kwong
• Keywords: 0301 basic medicine; Mice; 0303 health sciences; 03 medical and health sciences; Animals; Humans; Mice, Nude; Nanoparticles; Peptide Hydrolases; 3. Good health

Proteases are multi-functional enzymes that specialize in the hydrolysis of peptide-bonds and control broad biological processes including homeostasis and allostasis. Moreover, dysregulated protease activity drives pathogenesis and is a functional biomarker of diseases such as cancer; therefore, the ability to detect protease activity in vivo may provide clinically relevant information for biomedical diagnostics. The goal of this protocol is to create nanosensors that probe for protease activity in vivo by producing a quantifiable signal in urine. These protease nanosensors consist of two components: a nanoparticle and substrate. The nanoparticle functions to increase circulation half-life and substrate delivery to target disease sites. The substrate is a short peptide sequence (6-8 AA), which is designed to be specific to a target protease or group of proteases. The substrate is conjugated to the surface of the nanoparticle and is terminated by a reporter, such as a fluorescent marker, for detection. As dysregulated proteases cleave the peptide substrate, the reporter is filtered into urine for quantification as a biomarker of protease activity. Herein we describe construction of a nanosensor for matrix metalloproteinase 9 (MMP9), which is associated with tumor progression and metastasis, for detection of colorectal cancer in a mouse model.